Resultados del seguimiento de pacientes con carcinoma diferenciado de tiroides en Castilla-La Mancha (2001-2015). Estudio CADIT-CAM

Sastre Marcos, Julia; Aznar, Silvia; Álvarez, Visitación; Torres, Belvis; Delgado, Manuel; González, Javier; Quiroga, Iván.
Endocrinol. diabetes nutr. (Ed. impr.) ; 66(3): 164-172, mar. 2019. graf, tab
Artículo en Español | IBECS (España) | ID: ibc-182616

Documentos relacionados

  1. Pediatric liposarcoma: A case series and literature review.
  2. An overview on liposarcoma subtypes: Genetic alterations and recent advances in therapeutic strategies.
  3. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
  4. Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma.
  5. Recurrent metastatic retroperitoneal dedifferentiated liposarcoma: a case report and literature review.
  6. Pleomorphic Liposarcoma Unraveled: Investigating Histopathological and Immunohistochemical Markers for Tailored Diagnosis and Therapeutic Innovations.
  7. [Large excoriated pleomorphic liposarcoma].
  8. Treatment of De-Differentiated Liposarcoma in the Era of Immunotherapy.
  9. Dedifferentiated Liposarcoma: Systemic Therapy Options.
  10. The histological variants of liposarcoma: predictive MRI findings with prognostic implications, management, follow-up, and differential diagnosis.